Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Howmet Aerospace Inc (HWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Howmet Aerospace Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Howmet Aerospace Inc trades at $225.24 (market cap $88.76B). The key difference: Howmet Aerospace Inc is far larger — about 7.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Howmet Aerospace Inc pays a 0.25% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Howmet Aerospace Inc for 35 Days on average.
| HALO | HWM | |
|---|---|---|
Market Cap | $12.58B | $88.76B |
Volume | 2,179,278 | 2,648,516 |
Sector | Health | Industrials |
52-Week High | $115.22 | $292.65 |
52-Week Low | $61.63 | $184.09 |
Typical Hold Time | 1 Days | 35 Days |
Enterprise Value | $14.49B | $92.86B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Howmet Aerospace (HWM) trades at $222.53, down 0.08% on the day, with technical indicators showing bearish momentum despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected on October 29. Analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $328.10 consensus price target representing significant upside potential from current levels.
HWM presents a compelling growth story with robust financial performance and strong defense aerospace demand, though technical weakness and high valuation multiples warrant caution. The stock's 47.97 P/E ratio reflects premium pricing, but continued earnings growth and upcoming Q3 results could validate current optimism. Key risks include supply chain challenges and competitive pressures in the aerospace sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →
